NEW YORK, NY / ACCESSWIRE / January 15, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf ...

Shares of Intra-Cellular Therapies are surging 35% in premarket trading Monday after Johnson & Johnson said it will acquire ...

Intra-Cellular Therapies makes Caplyta, a once-daily pill for adults with schizophrenia and bipolar-related depression ...

Coming into Monday trading, Intra-Cellular stock was up about 40% over the past 12 months. Write to Elsa Ohlen at ...

Political novice Renard Johnson's business acumen, community work brings new leadership style to mayor's office.

Johnson & Johnson just announced a major acquisition to boost its position in the biopharmaceutical market. Quantum computing ...

Johnson & Johnson (JNJ – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Tim ...

Pharmaceutical giants have recently shown new enthusiasm for mental-health treatments with vast but unrealized promise.

This fall, pharmaceutical and medical technology company Johnson & Johnson announced that a newly created Dallas subsidiary filed a voluntary prepackaged Chapter 11 bankruptcy case to resolve more ...

Johnson & Johnson (NYSE:JNJ – Get Free Report) was the target of a significant decrease in short interest in the month of December. As of December 15th, there was short interest totalling 17,570,000 ...

TITUSVILLE, N.J., Jan. 8, 2025 /PRNewswire/ -- Johnson & Johnson (NYSE ... the second Fast Track designation granted in 2024 for the Company's AD portfolio. J&J's anti-tau active immunotherapy ...

Ald. Raymond Lopez want to test a technology that helps police identify and respond to gunshots, but he needs city approval.